Filtern
Erscheinungsjahr
- 2021 (2)
Dokumenttyp
- Zeitschriftenartikel (1)
- Corrigendum (1)
Sprache
- Englisch (2)
Schlagworte
- Antigens (1)
- Autoantibodies (1)
- Citrullinated (1)
- Protein-modification (1)
- Rheumatoid arthritis (1)
Organisationseinheit der BAM
Background: There is a need for biomarker to identify patients “at risk” for rheumatoid arthritis (risk-RA) and to better predict the therapeutic response and in this study we tested the hypothesis that novel native and citrullinated heterogeneous nuclear ribonucleoprotein (hnRNP)-DL autoantibodies could be possible biomarkers.
Methods: Using protein macroarray and ELISA, epitope recognition against hnRNP-DL was analysed in sera from different developed RA disease and diagnosed SLE patients. Toll-like receptor (TLR) 7/9 and myeloid Differentiation primary response gene 88 (MyD88)-dependency were studied in sera from murine disease models. HnRNP-DL expression in cultivated cells and synovial tissue was analysed by indirect immunofluorescence, immunoblot and immunohistochemistry.